Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP756131.RA9P6i-0D2v4z0ET7ZHeya0lTYPigJJTl0ncRhrqYNvo8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP756131.RA9P6i-0D2v4z0ET7ZHeya0lTYPigJJTl0ncRhrqYNvo8130_assertion type Assertion NP756131.RA9P6i-0D2v4z0ET7ZHeya0lTYPigJJTl0ncRhrqYNvo8130_head.
- NP756131.RA9P6i-0D2v4z0ET7ZHeya0lTYPigJJTl0ncRhrqYNvo8130_assertion description "[These could include monoclonal antibodies targeted to pancreatic tumor tissue, and possibly pancreatic site-specific P450's, as well as biomolecular/genetic techniques, particularly when focused on individuals at high risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756131.RA9P6i-0D2v4z0ET7ZHeya0lTYPigJJTl0ncRhrqYNvo8130_provenance.
- NP756131.RA9P6i-0D2v4z0ET7ZHeya0lTYPigJJTl0ncRhrqYNvo8130_assertion evidence source_evidence_literature NP756131.RA9P6i-0D2v4z0ET7ZHeya0lTYPigJJTl0ncRhrqYNvo8130_provenance.
- NP756131.RA9P6i-0D2v4z0ET7ZHeya0lTYPigJJTl0ncRhrqYNvo8130_assertion SIO_000772 2195363 NP756131.RA9P6i-0D2v4z0ET7ZHeya0lTYPigJJTl0ncRhrqYNvo8130_provenance.
- NP756131.RA9P6i-0D2v4z0ET7ZHeya0lTYPigJJTl0ncRhrqYNvo8130_assertion wasDerivedFrom befree-20140225 NP756131.RA9P6i-0D2v4z0ET7ZHeya0lTYPigJJTl0ncRhrqYNvo8130_provenance.
- NP756131.RA9P6i-0D2v4z0ET7ZHeya0lTYPigJJTl0ncRhrqYNvo8130_assertion wasGeneratedBy ECO_0000203 NP756131.RA9P6i-0D2v4z0ET7ZHeya0lTYPigJJTl0ncRhrqYNvo8130_provenance.